Aureka Biotechnologies
PrivateLast Round
Series B
Aug 10, 2026
Total Funding Raised
$200M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Aureka Biotechnologies is a biotechnology company that develops a therapeutic discovery platform using generative AI and high-throughput screening to design and discover antibody therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aureka Biotechnologies Comparables
Compare Aureka Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BigHat Biosciences | 88% | |
| Antiverse | 87% | |
| Infinimmune | 85% |
Aureka Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 10, 2026 | ||||
| Series A Extension | Apr 28, 2026 | ||||
| Series A | Nov 10, 2025 | ||||
| Seed | Mar 1, 2024 | ||||
| Seed | Jun 25, 2023 |
Aureka Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series B |
| BioTrack Capital | Series A Extension |
| Boyuan Capital | Series A Extension |
| Highlight Capital | Series B |
| Granite Asia | Series B |
| 5Y Capital | Series A Extension, Series A |
| NRL Capital | Series A Extension, Series B, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 119% MoM, reaching 5.9K.
- Aug 10, 2026
$100M round led by Granite Asia.
Recent news
Latest coverage and updates
- receives_financingAug 11, 2026
Aurekabio received financing of $100M in Series B on Aug 10th '26.
- is_developingAug 10, 2026
Aurekabio is developing biological world model.
- launchesJul 7, 2026
Aurekabio launched OpenDDE on Jul 7th '26.
- launchesJul 7, 2026
Aurekabio launched Open Drug Discovery Engine on Jul 7th '26.
Aureka Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aureka Biotechnologies's valuation, stock price, and market status.
Is Aureka Biotechnologies a public or private company?
Aureka Biotechnologies is a private company.
What is the current stock price of Aureka Biotechnologies?
Aureka Biotechnologies is a private company with no public stock price. No recent secondary market data is available.
How much is Aureka Biotechnologies worth (valuation)?
Valuation information for Aureka Biotechnologies is not publicly available.
Can I buy Aureka Biotechnologies stock?
Aureka Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aureka Biotechnologies's last funding round?
Aureka Biotechnologies's most recent funding round was Series A Extension on April 28, 2026.
Who are the main investors in Aureka Biotechnologies?
Key investors in Aureka Biotechnologies include HongShan, 5Y Capital, NRL Capital, 险峰K2VC, Qiming Venture Partners.
Will Aureka Biotechnologies IPO soon?
No public IPO plans have been announced for Aureka Biotechnologies.
How can I track Aureka Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aureka Biotechnologies's secondary market activity and sign up for updates.